Popular Articles

Link Between DNA Variations And Brain Tumors
Mayo Clinic researchers and colleagues at the University of California San Francisco (UCSF) have found a connection between DNA alterations on human chromosome 9 and aggressive brain cancer known as glioblastoma. The findings are reported in the current online issue of Nature Genetics.
drugs without prescription
Paclitaxel Poliglumex (OPAXIO(TM)) Added To Cisplatin And Radiation Produces 45% Pathologic Complete Remissions In Patients With Esophageal Cancer
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced that, in a study released from Brown University at the 2009 American Society for Clinical Oncology (ASCO) Annual Meeting, patients with cancer of the lower esophagus had evidence of a high pathological complete response ("CR") rate when given OPAXIO, a biologically enhanced paclitaxel, in addition to cisplatin and full-course radiotherapy.
News of the day
Cancer Patients Benefit From Speed, Accuracy Of RapidArc Radiotherapy Treatments
Peter Campbell, 65, was struggling to find the words to communicate. When his wife asked what his name was and where he lived, he couldn"t think of the answers. Following a CT scan of his brain, he learned that an aggressive type of brain tumor was hindering his speech and language functions. The tumor was removed surgically, and as is standard for treating this type of brain tumor, Campbell began a seven-week course of radiotherapy that is targeting the area where the lesion was removed, in order to kill any cancer cells that might have been left behind.
Nutrition

Hatwig Receives American Society of Health-System Pharmacists Award Of Excellence

The American Society of Health-System Pharmacists (ASHP) today honored Christopher A. Hatwig, M.S., FASHP, with the ASHP Board of Directors Award of Excellence for his work to help safety net hospitals provide safe and cost-effective drug therapy to low-income and uninsured patients. Hatwig, vice president of Apexus in Irving, Texas, received the award during ASHP"s Summer Meeting in Rosemont, Ill. Apexus is responsible for managing the Health Res and Services Administration"s (HRSA) 340B Prime Vendor Program. Mr. Hatwig works closely with HRSA"s Office of Pharmacy Affairs and the Pharmacy Services Support Center in Washington, D.C. to educate all stakeholders, and to improve the integrity and value of the 340B Drug Pricing Program for the nation"s safety-net providers. Under his leadership, the program generated savings of over $24 million or an average savings of 16 percent below the federal 340B ceiling price on its contracted products in 2008. Apexus is a wholly owned non-profit subsidiary of Provista Inc. Before joining Apexus, Hatwig was the director of ambulatory pharmacy services and value analysis programs at Parkland Health & Hospital System in Dallas where he practiced for 13 years. At Parkland he managed one of the nation"s largest and more progressive ambulatory pharmacy programs serving the low-income and uninsured. He was responsible for managing Parkland"s network of ambulatory pharmacies, which processed over two million prescriptions annually and operated with a drug expense budget of $65 million. "Mr. Hatwig"s work with the 340B program ensures that the most vulnerable patients in our country have access to the critical medications that they need and the expertise of pharmacists to guide their use," said Kevin J. Colgan, M.A., FASHP. "We are pleased to recognize his efforts with the Award of Excellence." Hatwig has made numerous presentations on the 340B drug pricing program, innovative ambulatory pharmacy services, and drug cost containment strategies. He has served as chair of the ASHP Council on Administrative Affairs and is a reviewer for the American Journal of Health-System Pharmacy. He is also a member of the Texas Society of Health-System Pharmacists and the Academy of Managed Care Pharmacy. Mr. Hatwig received his bachelor"s degree in pharmacy from the University of Arkansas and completed residencies in hospital pharmacy and hospital pharmacy administration at the University of Wisconsin, where he also received a master"s degree in hospital pharmacy. American Society of Health-System Pharmacists


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):